Alkermes plc (ALKS)

NasdaqGS Currently down 0.78 (-1.66%) in today's trading session

1 member of Congress has disclosed 1 trade in Alkermes plc (ALKS) via STOCK Act filings. The most recent disclosure was a purchase by Gilbert Cisneros on 30 July 2026. Aggregate disclosed activity totals roughly $32.5K in purchases (midpoint estimates from bracketed disclosure amounts).

Alkermes plc is currently trading at $46.10, positioned at 69% of its 52-week range ($25.17 – $55.67).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$46.10
24h Change
-0.78 (-1.66%)
52 Week Range
$25.17$55.67
View on NASDAQ

Alkermes plc Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for ALKS

Select to highlight on chart
1 transactions
Compliance: 100%
Gilbert Cisneros30 Jul 20264 Sept 2026PurchaseStock$15,001 - $50,000-4.63%

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$7.73B

Volume

1.06M

Beta

0.26

P/E Ratio

48.53

Fundamentals

EPS

$0.95

Div. Yield

-

Open

$46.14

Day Range

$45.80 – $46.93

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ · USD
Country
IE
CEO
Blair Jackson
IPO Date
1991-07-16

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The...

Earnings

Next Report

Q3 2026

28 Oct

EPS Est.

$-0.08

Rev. Est.

$463.9M

Days Until

51

Recent Quarters

Q2 202628 Jul
EPS$0.70
Beat 2650.1%
Q1 20265 May
EPS$-0.40
Beat 29.8%
Q4 202525 Feb
EPS$0.34
Miss 20.9%
Q3 202528 Oct
EPS$0.49
Beat 32.9%
Q2 202529 Jul
EPS$0.52
Beat 26.8%
Q1 20251 May
EPS$0.13
Miss 48.9%
Q4 202412 Feb
EPS$1.04
Beat 28.4%
Q3 202424 Oct
EPS$0.72
Miss 2.7%
Q2 202424 Jul
EPS$0.70
Beat 0.0%
Q1 20241 May
EPS$0.44
Miss 25.4%
Q4 202315 Feb
EPS$0.22
Miss 52.2%
Q3 202325 Oct
EPS$0.64
Beat 45.5%
Q2 202326 Jul
EPS$0.55
Beat 14.6%
Q1 202326 Apr
EPS$0.01
Beat 174.0%
Q4 202216 Feb
EPS$0.14
Beat 180.0%
Q3 20222 Nov
EPS$0.02
Miss 34.1%
Q2 202227 Jul
EPS$0.06
Beat 740.3%
Q1 202227 Apr
EPS$0.12
Beat 1066.2%
Q4 202116 Feb
EPS$0.23
Beat 76.9%
Q3 202127 Oct
EPS$0.14
Beat 75.0%
Q2 202128 Jul
EPS$0.30
Beat 150.0%
Q1 202128 Apr
EPS$0.11
Beat 320.0%
Q4 202011 Feb
EPS$0.10
Beat 42.9%
Q3 202029 Oct
EPS$0.26
Beat 12900.0%
Q2 202029 Jul
EPS$0.06
Beat 600.1%
Q1 202029 Apr
EPS$0.01
Beat 112.5%
Q4 201913 Feb
EPS$0.83
Beat 25.8%
Q3 201923 Oct
EPS$-0.04
Beat 80.0%
Q2 201925 Jul
EPS$0.09
Beat 190.0%
Q1 201925 Apr
EPS$-0.17
Beat 10.5%
Q4 201814 Feb
EPS$0.34
Beat 666.7%
Q3 201823 Oct
EPS$0.07
Beat 216.7%
Q2 201826 Jul
EPS$0.29
Beat 190.0%
Q1 201826 Apr
EPS$-0.09
Miss 12.5%
Q4 201714 Feb
EPS$0.31
Beat 47.6%
Q3 201726 Oct
EPS$0.03
Beat 444.5%
Q2 201727 Jul
EPS$0.01
Beat 207.7%
Q1 201727 Apr
EPS$-0.18
Miss 125.0%
Q4 201615 Feb
EPS$0.15
Beat 289.6%
Q3 20162 Nov
EPS$-0.09
Miss 50.0%
Q2 201628 Jul
EPS$-0.01
Beat 90.0%
Q1 201628 Apr
EPS$-0.16
Beat 20.0%
Q4 201525 Feb
EPS$-0.15
Beat 21.1%
Q3 201529 Oct
EPS$-0.18
Beat 10.0%
Q2 201530 Jul
EPS$-0.09
Miss 12.5%
Q1 201530 Apr
EPS$0.06
Beat 200.0%
Q4 201424 Feb
EPS$0.11
Beat 207.4%
Q3 201429 Oct
EPS$0.03
Beat 30.4%
Q2 201431 Jul
EPS$0.11
Miss 21.4%
Q1 201430 Apr
EPS$0.11
Beat 10.0%
Q4 201327 Feb
EPS$0.12
Miss 36.8%
Q3 201331 Oct
EPS$0.22
Beat 4.8%
Q2 201325 Jul
EPS$0.05
Miss 77.3%
Q1 201323 May
EPS$0.02
Miss 89.5%
Q4 201231 Jan
EPS$0.20
Miss 16.7%
Q3 20121 Nov
EPS$0.10
Miss 23.1%
Q2 201226 Jul
EPS$0.17
Beat 6.3%
Q1 201217 May
EPS$-0.49
Miss 226.7%
Q4 20112 Feb
EPS$-0.11
Beat 47.6%
Q3 20113 Nov
EPS$-0.14
Miss 16.7%
Q2 20111 Aug
EPS$-0.04
Beat 63.6%
Q1 201118 May
EPS$-0.14
Beat 0.0%
Q4 20103 Feb
EPS$-0.12
Beat 20.0%
Q3 20104 Nov
EPS$-0.08
Beat 46.7%
Q2 20105 Aug
EPS$-0.14
Beat 0.0%
Q1 201013 May
EPS$-0.15
Beat 0.0%
Q4 20094 Feb
EPS$-0.07
Beat 56.3%
Q3 20095 Nov
EPS$-0.09
Beat 0.0%
Q2 20096 Aug
EPS$-0.11
Miss 37.5%
Q1 200921 May
EPS$-0.14
Miss 16.7%
Q4 20085 Feb
EPS$1.17
Miss 3.3%
Q3 20086 Nov
EPS$0.02
Beat 211.0%
Q2 20087 Aug
EPS$0.31
Beat 40.9%
Q1 200822 May
EPS$-0.19
Miss 100.0%
Q4 20077 Feb
EPS$-0.02
Miss 146.0%
Q3 20071 Nov
EPS$0.07
Beat 69.4%
Q2 20072 Aug
EPS$0.08
Beat 86.7%
Q1 200729 May
EPS$0.03
Beat 150.0%
Q4 20067 Feb
EPS$0.03
Q3 20062 Nov
EPS$0.04
Beat 194.6%
Q2 20068 Aug
EPS$-0.01
Q1 200618 May
EPS$0.04
Beat 201.4%
Q4 20057 Feb
EPS$0.02
Beat 125.0%
Q3 20053 Nov
EPS$0.12
Beat 209.1%
Q2 20054 Aug
EPS$-0.15
Beat 16.7%
Q1 200519 May
EPS$-0.16
Beat 5.9%
Q4 20043 Feb
EPS$-0.10
Beat 28.6%
Q3 20044 Nov
EPS$-0.16
Beat 23.8%
Q2 20045 Aug
EPS$-0.29
Miss 45.0%
Q1 200413 May
EPS$-0.28
Miss 64.7%
Q4 200311 Feb
EPS$-0.23
Beat 17.9%
Q3 20035 Nov
EPS$-0.31
Miss 34.8%
Q2 20037 Aug
EPS$-0.44
Miss 51.7%
Q1 200329 May
EPS$-0.30
Beat 6.3%
Q4 200212 Feb
EPS$-0.20
Beat 35.5%
Q3 20027 Nov
EPS$-0.41
Miss 32.3%
Q2 200214 Aug
EPS$-0.33
Miss 3.1%
Q1 200227 Jun
EPS$-0.35
Miss 12.9%
Q4 200114 Feb
EPS$-0.28
Miss 3.7%
Q3 20018 Nov
EPS$-0.20
Beat 20.0%
Q2 200114 Aug
EPS$-0.13
Beat 45.8%
Q1 200123 May
EPS$-0.22
Beat 31.3%
Q4 200013 Feb
EPS$-0.17
Beat 51.4%
Q3 200013 Nov
EPS$-0.19
Beat 44.1%
Q2 200014 Aug
EPS$0.13
Beat 218.2%
Q1 200028 Jun
EPS$-0.59
Miss 84.4%
Q4 199914 Feb
EPS$-0.38
Miss 35.7%
Q3 199915 Nov
EPS$-0.33
Miss 10.0%
Q2 199916 Aug
EPS$-0.20
Beat 25.9%
Q1 199924 Jun
EPS$-0.30
Miss 11.1%
Q4 199812 Feb
EPS$-0.09
Beat 40.0%
Q3 199813 Nov
EPS$-0.10
Beat 16.7%
Q3 19987 Oct
EPS$-0.09
Beat 10.0%
Q1 19985 Jun
EPS$-0.04
Beat 66.7%
Q4 199711 Feb
EPS$-0.07
Beat 30.0%
Q3 199711 Nov
EPS$-0.02
Beat 81.8%
Q2 19978 Aug
EPS$-0.09
Beat 25.0%
Q1 199723 May
EPS$-0.12
Beat 20.0%
Q4 199617 Jan
EPS$-0.11
Beat 21.4%
Q3 19968 Nov
EPS$-0.13
Beat 7.1%
Q2 199612 Aug
EPS$-0.14
Beat 6.7%
Q1 199621 Jun
EPS$-0.18
Miss 28.6%
Q4 199514 Feb
EPS$-0.08
Beat 33.3%
Q3 199513 Nov
EPS$-0.11
Miss 10.0%
Q2 19959 Aug
EPS$-0.09
Beat 18.2%
Q1 199522 Jun
EPS$-0.12
Miss 71.4%
Q4 199410 Feb
EPS$-0.07
Beat 36.4%
Q3 199414 Nov
EPS$-0.11
Beat 38.9%
Q2 199415 Aug
EPS$-0.13
Beat 0.0%
Q1 199428 Jun
EPS$-0.14
Beat 22.2%
Q4 199315 Feb
EPS$-0.18
Beat 0.0%
Q3 199315 Nov
EPS$-0.14
Beat 22.2%
Q2 199317 Aug
EPS$-0.17
Miss 41.7%
Q1 199330 Jun
EPS$-0.18
Q3 199231 Dec
EPS$-0.10
Q2 199230 Sept
EPS$-0.11
Q1 199230 Jun
EPS$-0.05
Q4 199131 Mar
EPS$-0.13
Q3 199131 Dec
EPS$-0.08
Q2 199130 Sept
EPS$-0.11
Q1 199130 Jun
EPS$-0.12

No dividend data available for this stock.

Stock Splits

Split History

15 May 2000Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ALKS

Which members of Congress have traded ALKS?
1 member of Congress has disclosed 1 trade in Alkermes plc (ALKS) under the STOCK Act: Gilbert Cisneros.
When was ALKS most recently disclosed by Congress?
The most recent ALKS disclosure was a purchase by Gilbert Cisneros on 30 July 2026.
What is the total disclosed congressional trading volume for ALKS?
Members of Congress have disclosed approximately $32.5K in ALKS purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in ALKS?
This ALKS page updates as soon as new STOCK Act disclosures are filed for Alkermes plc. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.